BioSpace News Archive

Bruker Corporation (Nasdaq: BRKR) announced financial results for its fourth quarter and fiscal year ended December 31, 2018.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of inducement equity awards to eight newly hired employees.

CONMED Corporation announced that it has completed its previously announced acquisition of privately-held Buffalo Filter LLC from Filtration Group.

FullMast Men’s Health Clinics, specializing in the treatment of erectile dysfunction using SONICWAVE™ therapy, has opened a clinic located on the border of Oakville and Mississauga.

AIVITA Biomedical, Inc. announced that the Company’s revolutionary stem-cell based ROOT OF SKIN™ skincare line sold out again during its fifth appearance on the Japanese home shopping channel QVC Japan.

Aethlon Medical, Inc., a therapeutic technology company focused on unmet needs in global health, reported financial results for the third quarter ended December 31, 2018 and provided an update on recent developments.

Intersect ENT, Inc. announced that it will release fourth quarter and year 2018 financial results on February 25, 2019.

IntraBio Inc., a late-stage biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) Application for Clinical Trial IB1001-202 involving its lead compound (IB1001) for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease).

Atlas Analytical Inc., a microbiology and chemistry quality control laboratory, has just completed its move to a newly expanded site in Brooksville, Florida.

Surveillance is the cornerstone of public health practice, yet while disease surveillance has shifted toward greater use of electronically transmitted information to decrease the reporting burden on physicians, the challenge of getting the right information to public health officials at the right time has not been completely solved.